Steinhart Richard I
BioXcel Therapeutics, Inc. · Chief Financial Officer
Steinhart Richard I is listed in filings as Chief Financial Officer at BioXcel Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 22, 2026, including sale activity. Recent filings connect the profile to BioXcel Therapeutics, Inc. (BTAI), Atossa Therapeutics, Inc. (ATOS), and Actinium Pharmaceuticals, Inc. (ATNM). The current snapshot covers public activity from Jun 18, 2024 to May 22, 2026. Reported amounts are shown as $7.4K to $357.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $133372 shares | SellDec 16, 2024 | $0.358 | $1.26 | |
| $74205 shares | SellDec 16, 2024 | $0.36 | $1.26 | |
| $3.9k7.2k shares | SellOct 3, 2024 | $0.55 | $1.26 | |
| $246356 shares | SellSep 16, 2024 | $0.6899 | $1.26 | |
| $470372 shares | SellJun 17, 2024 | $1.26 | $1.26 |